St. Jude Halts Portico TAVR Implants Based On IDE Study Imaging Data
This article was originally published in The Gray Sheet
Executive Summary
The firm says it is temporarily halting implants of its transcatheter aortic health valve replacement worldwide while it reviews CT data showing reduced valve leaflet mobility in some patients treated as part of St. Jude’s U.S. pivotal trial.